Memory Loss: What is Normal Aging?
Neurologist Sharon Sha, MD, discusses dementia and aging at Stanford's 5th Annual Women's Health Forum.
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
Get the iPhone MyHealth app »
Get the Android MyHealth app »
The Stanford Center for Memory Disorders is dedicated to the fight against cognitive decline. There are many different causes of memory loss, and an accurate diagnosis by an experienced team is essential to getting the best treatment.
The Center is one of only about 30 National Institutes of Health (NIH) designated Alzheimer’s Disease Centers in the United States, a designated Alzheimer’s Disease Research Center, and one of 24 Lewy Body Dementia (LBD) Research Centers of Excellence, helping to advance LBD care, community outreach, and connecting patients with the latest LBD clinical trials.
The Stanford Health Care Center for Memory Disorders is encouraged that there is a new treatment option for certain patients with Alzheimer’s disease. On January 6, 2023, the FDA granted accelerated approval for lecanemab (LeqembiTM).
At the Stanford Center for Memory Disorders, we are as passionate about research as we are about taking care of patients. Our research spans a full spectrum, from bench to bedside: In basic science labs, we investigate the fundamental causes of Alzheimer's disease and creating novel treatments. Other faculty study advanced neuroimaging technologies and lab-based studies of blood samples, in an effort to make early diagnosis possible.
The same faculty members who care for patients also contribute to research on Alzheimer's disease and other neurodegenerative disorders. Stanford has numerous basic science labs investigating the fundamental causes of Alzheimer's disease and creating novel treatments. Our faculty brings advanced neuroimaging technologies and lab-based studies of blood samples to human research subjects in clinical trials, in an effort to make early diagnosis possible.
Neurologist Sharon Sha, MD, discusses dementia and aging at Stanford's 5th Annual Women's Health Forum.
Susan Harvell's memory lapses signaled early-onset Alzheimer's disease. Getting a clear diagnosis at Stanford has allowed her to plan her future with her family.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
For your convenience, you may check in for all same-day appointments at the Stanford Neuroscience Health Center through a centralized, check-in desk near the front lobby. In addition to all outpatient services, you also can access onsite pre-surgery consultations at the center.
Call us to make, change or reschedule an appointment.
International Patients
Phone: +1 650-723-8561
Email: IMS@stanfordhealthcare.org
Any patient with a progressive neurological syndrome that includes cognitive or behavioral symptoms is appropriate for referral. The earlier you refer a patient, the better. Patients with mild cognitive impairment may benefit the most from diagnosis and treatment, especially as emerging therapies become available. We see patients for one-time consultations, second opinions, and for longitudinal care.
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday – Friday, 8:30 a.m. – 5 p.m.
Phone: 1-800-800-1551, 24 hours - 7 days a week
Stanford Health Care provides comprehensive services to refer and track patients, as well as provides the latest information and news for physicians and office staff. For help with all referral needs and questions visit Referring Physicians.
To request an appointment, call 650-723-6469.